736 related articles for article (PubMed ID: 37437245)
1. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
Meng Q; Schatten H; Zhou Q; Chen J
Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
[TBL] [Abstract][Full Text] [Related]
2. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
[TBL] [Abstract][Full Text] [Related]
3. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.
Ma W; Wu T
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1190-C1205. PubMed ID: 36036444
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
Front Oncol; 2022; 12():927640. PubMed ID: 35936737
[TBL] [Abstract][Full Text] [Related]
5. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
6. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
7. The functions of N6-methyladenosine modification in lncRNAs.
He RZ; Jiang J; Luo DX
Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
[TBL] [Abstract][Full Text] [Related]
9. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
10. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine links RNA metabolism to cancer progression.
Dai D; Wang H; Zhu L; Jin H; Wang X
Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
[TBL] [Abstract][Full Text] [Related]
12. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
13. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
[TBL] [Abstract][Full Text] [Related]
15. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
Liao Y; Han P; Zhang Y; Ni B
Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-wide profiling identifies colon cancer-associated m6A transcripts and potential RNA methyl modifiers.
Ramasamy D; Thippannah M; Maharajan HRP; Balaiah M; Seshadri RA; Kodous AS; Herceg Z; Mehta A; Rao AKDM; Mani S
Mol Biol Rep; 2024 Feb; 51(1):299. PubMed ID: 38345740
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
Jayasree PJ; Dutta S; Karemore P; Khandelia P
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
20. Link Between m6A Modification and Cancers.
Liu ZX; Li LM; Sun HL; Liu SM
Front Bioeng Biotechnol; 2018; 6():89. PubMed ID: 30062093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]